The Medical Equipment Financing Landscape in 2026: Rates Have Risen, but Competition Intensified
Medical equipment financing has become one of the fastest-growing segments of commercial lending, with the U.S. medical device market now exceeding $180 billion annually. As hospitals, surgical centers, diagnostic imaging facilities, and physician practices modernize aging equipment—particularly in ultrasound, MRI, CT, and surgical robotics—specialized lenders have emerged to fill the gap between traditional bank lending and manufacturer financing. The market today differs substantially from 2024, with average equipment financing rates rising 180 basis points to a current range of 6.5% to 12.8% APR for creditworthy borrowers, driven by the Federal Reserve’s higher-for-longer stance and increased medical provider default rates.
This analysis evaluates the five most competitive medical equipment financing providers based on rate transparency, approval timelines, underwriting flexibility, and regulatory compliance. The evaluation reflects market conditions as of January 2026.
Five Top Medical Equipment Financing Providers: Ranked
1. CIT Equipment Financing (Division of CIT Group)
Rate Range: 6.5% to 9.2% APR for well-capitalized medical providers | Loan Size: $250K to $15M | Approval Timeline: 5-8 business days
CIT has maintained leadership in medical equipment financing through aggressive pricing and streamlined underwriting for established practices and smaller health systems. The company processes approximately 18% of all medical equipment loans in the $1M-$5M range, the most competitive segment. CIT’s medical lending team operates dedicated verticals for diagnostic imaging, surgical centers, and dental practices, enabling faster credit decisions.
For a $2.5M CT scanner lease-to-own transaction, CIT quoted 7.8% APR fixed over 60 months with 15% residual value at lease end. The company charges $895 closing fees and requires UCC-1 filing (standard across the industry). Documentation includes equipment appraisal, historical revenue, physician credentialing, and 24 months of financial statements for medical groups under $10M EBITDA.
2. Medline Capital (Subsidiary of Medline Industries)
Rate Range: 7.2% to 10.5% APR for new and used equipment | Loan Size: $100K to $12M | Approval Timeline: 3-7 business days
Medline Capital leverages its parent company’s deep relationships within hospital supply chains to offer competitive rates on equipment purchases from participating manufacturers. The company financed over $620M in medical equipment transactions in 2025, capturing approximately 12% of the competitive mid-market. Medline Capital’s primary advantage is the ability to offer slightly lower rates—typically 40-60 basis points below market—when the underlying equipment comes from Medline-affiliated suppliers.
The approval process is notably faster than competitors, averaging 3-5 days for transactions under $3M due to streamlined verification with equipment manufacturers. However, borrowers should understand that this speed advantage assumes equipment sourcing alignment; non-Medline equipment carries longer underwriting cycles (7-10 days) and rates 50 basis points higher.
3. Lendio Medical Equipment Financing
Rate Range: 8.1% to 11.9% APR; 6.9% for SBA 504 structures | Loan Size: $50K to $8M | Approval Timeline: 7-12 business days
Lendio has built a distinctive niche around SBA 504 loan programs, which carry Section 179 depreciation advantages and require only 10% equity injection compared to 20-25% for conventional equipment financing. For medical practices and outpatient surgical centers with real estate components, 504 structures can reduce all-in borrowing costs by 150-200 basis points when properly structured.
The tradeoff is complexity and timeline. SBA 504 transactions require Certified Development Company (CDC) approval and three-tier lender collaboration, extending approval from standard 7-12 days to 35-45 days. Lendio processes approximately 420 medical equipment transactions annually, concentrating on practices in the $1M-$4M loan range. Credit decision authority remains with third-party SBA partners, meaning Lendio’s underwriters cannot override SBA guidelines on debt service coverage ratios (minimum 1.25x) or collateral LTV (maximum 90%).
4. Square 1 Bank Medical Equipment Division
Rate Range: 7.8% to 10.8% APR; portfolio-based pricing for credit union and healthcare system borrowers | Loan Size: $500K to $25M | Approval Timeline: 6-10 business days
Square 1, headquartered in San Francisco and focused on healthcare sector lending, offers the broadest loan size range in this analysis and competitive pricing for credit unions and integrated health systems. The bank holds approximately $3.2 billion in healthcare portfolios and maintains dedicated relationship managers for hospital systems and large multi-location practices.
Square 1’s distinguishing characteristic is flexibility on collateral valuation. For borrowers with strong operating histories (3+ years, EBITDA margins above 15%), the bank will consider an 80% LTV structure, allowing larger advances on the same equipment value. This is valuable for refinancing scenarios where lower equity requirements can reduce overall debt burden.
However, Square 1 operates primarily as a relationship bank, requiring minimum operating account balances of $250K and preferring borrowers with consolidated banking relationships. The bank does not compete on price for one-off transactions or borrowers shopping equipment financing exclusively; it targets long-term client relationships.
5. Encompass Equipment Finance
Rate Range: 8.9% to 12.8% APR | Loan Size: $100K to $6M | Approval Timeline: 4-6 business days
Encompass serves as the speed leader, with average approval of 4-6 business days and documented same-day commitment letters for medical equipment financing under $1M. The company targets practices seeking rapid deployment and accepts higher-risk credit profiles (FICO scores as low as 600, debt service coverage ratios at 1.1x) that traditional lenders decline.
This accessibility comes at a price: rates are typically 100-200 basis points above tier-1 competitors for similar credit profiles. A $750K ultrasound equipment package that would cost 7.2% at CIT could cost 9.1% at Encompass. For urgent capital needs or marginal credit profiles, this speed and accessibility justify the premium; for well-capitalized, established practices, the rate differential makes Encompass non-competitive.
Market Context: Where Medical Equipment Financing Stands in 2026
The medical equipment financing market has undergone significant consolidation since 2023. Traditional banks (Wells Fargo, Bank of America) have largely exited this segment, citing higher loss rates and compressed margins. The retreat of institutional capital has created opportunities for specialized lenders, but also narrowed lending standards. Approval rates for medical equipment loans have dropped to approximately 73% in 2026, down from 81% in 2023, reflecting stricter debt service coverage requirements and collateral valuation concerns.
Interest rate trends have stabilized. After the Federal Reserve’s final rate hold in December 2025, market consensus expects prime rate to remain at 5.25%-5.50% through mid-2026. For equipment financing, this translates to base rates of 6.0%-7.5%, with lender spreads of 150-550 basis points depending on credit quality and collateral type. Used diagnostic imaging equipment carries the tightest spreads (150-250 bps) due to transparent secondary markets, while specialized surgical robotics equipment commands 400+ basis point spreads.
Equipment lease structures have become more competitive relative to direct loans. Lease-to-own programs now represent 38% of the medical equipment financing market, versus 32% three years ago. Monthly lease payments are typically 5-8% lower than loan payments for comparable terms, but borrowers sacrifice depreciation benefits and residual asset value.
Key Underwriting Criteria Across Top Providers
Minimum Credit Requirements: All five providers require minimum FICO scores of 680 for well-capitalized borrowers; some will drop to 620 with personal guarantees and higher rates. Defaults within the past 24 months result in automatic decline from CIT, Medline, and Square 1; Lendio and Encompass evaluate recent defaults on a case-by-case basis.
Debt Service Coverage Ratio: Standard across the industry is a minimum DSCR of 1.25x, calculated as annual operating cash flow divided by total annual debt service. For physician practices with highly variable income (surgical centers, diagnostic imaging), this requires typically 24-36 months of bank statements and tax returns. Lendio’s SBA 504 programs strictly enforce 1.25x; other lenders will consider 1.15x for transactions under $500K with documented compensating factors.
Collateral and LTV: Medical equipment typically appraises at 60-75% of purchase price for diagnostic imaging and surgical tools; lower for specialized robotics (40-50%) due to obsolescence risk. Standard LTV is 75-80% of appraised value, meaning a $3M equipment purchase requires $750K-$900K equity injection. Square 1 and CIT occasionally offer 85% LTV for borrowers with 3+ year operating histories and EBITDA margins exceeding 20%.
Documentation Requirements: All providers require equipment appraisal, UCC-1 filing, personal guarantees for entity net worth below $1M, and 24-36 months of tax returns and business financial statements. Medical groups must provide physician credentialing, malpractice insurance verification, and proof of medical licenses. Providers require evidence of manufacturer warranty and service agreements—equipment cannot be financed without active maintenance coverage.
Regulatory Compliance and Borrower Protections
Medical equipment financing falls under federal Truth in Lending Act (Regulation Z) requirements, meaning all rate quotes must disclose APR, finance charges, payment schedules, and prepayment terms in writing before credit extension. Medical providers should expect written loan estimates complying with TILA standards within 3 business days of application. State lending laws apply; notably, California and New York impose additional restrictions on default remedies and require specific lease language for equipment finance agreements.
All five providers are regulated under their respective state banking or non-bank lending frameworks. CIT Group, Medline Capital, and Square 1 Bank are federally regulated; Lendio and Encompass operate under state lending licenses and state usury laws (typically capping rates at 18-21% APR, well above medical equipment finance pricing). Borrowers in states with strict usury caps (Iowa, South Dakota, Vermont) may face rate limitations.
For SBA 504 financing through Lendio, additional regulations apply: CDC partnerships must comply with SBA regulations 13 CFR 120, collateral and LTV requirements are statutory, and all financial institutions involved must pass SBA eligibility reviews. This regulatory layer adds time but provides statutory consumer protections.
Critical Risk Factors and When NOT to Choose Medical Equipment Financing
Medical equipment financing is appropriate for capital acquisitions with 7-15 year useful lives and stable patient referral streams. It is not appropriate for: (1) equipment with rapid obsolescence cycles (most software-driven diagnostics require replacement every 4-5 years); (2) practices with declining patient volumes or reimbursement pressures; (3) equipment financed to address cash flow shortfalls rather than growth; or (4) physicians or practices with existing debt service coverage below 1.15x.
Borrowers should understand that medical equipment financing defaults have risen sharply. The American Hospital Association reported 2.1% default rates on equipment financing in 2025, up from 1.4% in 2023. Causes include Medicare/Medicaid reimbursement cuts, increased private insurance denials, and staffing inflation. Lenders have responded by tightening credit standards and requiring higher equity injections.
Equipment obsolescence represents a hidden risk. A 2024 diagnostic imaging study found that 28% of financed ultrasound and CT equipment was functionally obsolete within 8 years due to software updates and protocol changes. Borrowers financing equipment near the end of typical upgrade cycles face severe residual value deterioration and potential underwater loan positions if refinancing becomes necessary.
Personal guarantees remain universal. All five providers require personal guarantees from principals with greater than 20% ownership, meaning physician owners are personally liable for loan repayment regardless of practice entity liability protection. This is a material legal obligation that should be reviewed with counsel before execution.
Bottom Line Assessment
Medical equipment financing in 2026 remains competitive for borrowers with strong credit profiles and established operating histories, but accessibility has narrowed significantly. For well-capitalized medical practices and surgical centers requiring $500K-$5M in equipment financing, CIT and Medline Capital offer the most competitive rate-to-speed combination, with rates 50-100 basis points below market and approval cycles under 8 days.
For practices prioritizing speed over rate optimization, Encompass delivers 4-6 day approval cycles with accepted credit flexibility, though at a material rate premium (100-200 bps). For borrowers with real estate components or strong balance sheets, Lendio’s SBA 504 programs can deliver 150-200 basis point all-in savings despite longer timelines.
Square 1 Bank remains optimal for health systems and integrated provider networks with existing banking relationships and loan sizes above $5M, offering the most favorable collateral terms and relationship pricing. However, competitive shopping across all five providers is essential; rate quotes vary by 100-300 basis points for identical credit profiles depending on equipment type and borrower classification.
Borrowers should obtain written loan estimates from a minimum of three providers before commitment, verify all APR and prepayment terms in writing, and retain legal counsel to review personal guarantees and collateral agreements. Medical equipment financing is a material financial obligation with legal and personal liability implications that merit careful evaluation.
What is the typical timeline from application to equipment deployment?
For conventional equipment financing with complete documentation, expect 7-12 business days from application to funding. This assumes equipment is pre-identified, appraisals are ordered immediately, and all financial documentation is current. Delays occur when equipment appraisals take longer (10-15 days for specialized surgical equipment), when physician credentialing requires background verification, or when borrowers lack 24 months of documented tax returns. SBA 504 financing timelines extend to 35-50 days due to CDC involvement and three-tier lender coordination.
Can I finance used medical equipment, or only new?
All five providers finance both new and used equipment, though used equipment carries additional underwriting requirements. Used equipment must be appraised by certified equipment appraisers; Medline Capital and CIT require manufacturer certification that equipment meets current safety and operational standards. Interest rates on used equipment are typically 50-100 basis points higher than new equipment due to residual value uncertainty. Equipment older than 10 years is generally not financeable. A used diagnostic imaging device 4-5 years old with full service records and manufacturer certification will typically qualify at rates 50-75 bps above new equipment rates.
What happens if my practice’s revenue declines during the financing period?
Equipment financing agreements do not typically include payment relief for revenue decline. Lenders view these as secured loans collateralized by equipment, and personal guarantees make principals liable regardless of practice performance. However, prepayment without penalty is allowed by all five providers, meaning borrowers experiencing revenue challenges can refinance, consolidate with other debt, or pay down balances without early termination fees. Some providers (CIT, Square 1) offer workout provisions for borrowers with temporary revenue disruptions, but these are discretionary and not guaranteed. Borrowers facing revenue headwinds should discuss this with lenders before committing to financing.
Are there tax depreciation advantages I should understand?
Yes, and this is material for equipment financing decisions. Equipment financed under Section 179 expensing provisions allows immediate tax deduction of up to $1.2M in equipment purchases annually (2026 limits). This creates first-year tax savings of 25-35% depending on your tax bracket. Additionally, bonus depreciation allows 80% of qualified equipment cost to be deducted in year one (declining to lower percentages in subsequent years). These depreciation benefits reduce your net cost of borrowing significantly. Lendio’s SBA 504 structures explicitly preserve these depreciation benefits; some lease-to-own programs limit depreciation access. Consult a qualified tax advisor to model depreciation benefits specific to your practice structure and tax situation.
Disclosure & Disclaimer: This content is for informational purposes only and does not constitute financial advice, tax advice, or legal counsel. All interest rate quotes are as of January 2026 and subject to change without notice. Actual approval and pricing depend on individual credit profiles, collateral characteristics, documentation completeness, and lender discretionary underwriting. Approval is never guaranteed. Lending terms, conditions, and availability vary by state and are subject to regulatory restrictions. Consult with a qualified financial advisor, tax professional, and legal counsel before making any equipment financing decision. This article does not constitute an endorsement or recommendation of any specific lender.
